{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:14:55Z","timestamp":1792721695182,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013298","name":"Sociedad Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semarthrit.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T11:19:11Z","timestamp":1591010351000},"page":"776-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease"],"prefix":"10.1016","volume":"50","author":[{"given":"F.","family":"Romero-Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Diaz del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Trallero-Aragu\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Ruiz-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Castellvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Rodriguez-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Mart\u00ednez-Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sanchez-Pernaute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pinal-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Solanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Gonzalez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Selva-O'Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0001","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.03.007_bib0002","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0003","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10067-015-2935-9","article-title":"Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis\/dermatomyositis","volume":"34","author":"Chen","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0004","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.03.007_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti-melanoma differentiation-associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with amyopathic and myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0006","doi-asserted-by":"crossref","unstructured":"Labrador-Horrillo M, Martinez MA, Selva-O'Callaghan A. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. 2014;2014:290797.","DOI":"10.1155\/2014\/290797"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.03.007_bib0007","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3899\/jrheum.160682","article-title":"Antimelanoma differentiation-associated gene 5 antibody: expanding the clinical spectrum in north american patients with dermatomyositis","volume":"44","author":"Moghadam-Kia","year":"2017","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.03.007_bib0008","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.03.007_bib0009","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.03.007_bib0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/0961203316651748","article-title":"Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease","volume":"25","author":"Nakashima","year":"2016","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0011","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","article-title":"Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients","volume":"57","author":"Sato","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study","volume":"8","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0013","unstructured":"Grupo de trabajo sobre GPC. Elaboraci\u00f3n de Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el Sistema Nacional de Salud. Manual Metodol\u00f3gico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragon\u00e9s de Ciencias de la Salud-I+CS; 2007. Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el SNS: I+CS N\u00ba 2006\/0I."},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0014","unstructured":"L\u00f3pez de Argumedo M RE, Guti\u00e9rrez A, Bay\u00f3n JC. Actualizaci\u00f3n del Sistema de Trabajo Compartido para Revisiones Sistem\u00e1ticas de la Evidencia Cient\u00edfica y Lectura Cr\u00edtica (Plataforma FLC 3.0). Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias del Pa\u00eds Vasco; 2017. Informes de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias: OSTEBA."},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0016","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0017","first-page":"1","article-title":"Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review","author":"Hoa","year":"2017","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0018","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.03.007_bib0019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10067-012-2142-x","article-title":"Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"32","author":"Muro","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","article-title":"Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis","volume":"56","author":"Sakamoto","year":"2018","journal-title":"Respir Investig"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.03.007_bib0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/s10165-010-0371-x","article-title":"Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis","volume":"21","author":"Gono","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.03.007_bib0022","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0023","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/imj.12754","article-title":"Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study","volume":"45","author":"Chen","year":"2015","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0024","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2796.2011.02459.x","article-title":"KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis","volume":"271","author":"Fathi","year":"2012","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.03.007_bib0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/14397595.2018.1548918","article-title":"Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis","volume":"29","author":"Nishioka","year":"2019","journal-title":"Mod Rheumatol."},{"issue":"3","key":"10.1016\/j.semarthrit.2020.03.007_bib0026","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2169\/internalmedicine.8335-16","article-title":"The serum ferritin level is associated with the treatment responsivity for rapidly progressive interstitial lung disease with amyopathic dermatomyositis, irrespective of the anti-MDA5 antibody level","volume":"57","author":"Osawa","year":"2018","journal-title":"Internal Medicine"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.03.007_bib0027","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0028","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/s10165-011-0558-9","article-title":"Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140\/MDA5 autoantibodies","volume":"22","author":"Sato","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"8-9","key":"10.1016\/j.semarthrit.2020.03.007_bib0029","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.annder.2016.03.018","article-title":"[Extensive digital necrosis during dermatomyositis associated with MDA-5 antibodies]","volume":"143","author":"Charbit","year":"2016","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/14397595.2014.908811","article-title":"Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease","volume":"26","author":"Fujimoto","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0031","first-page":"1","article-title":"Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review","author":"Gonz\u00e1lez-Moreno","year":"2018","journal-title":"Rheumatology International"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.03.007_bib0032","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jbspin.2014.01.005","article-title":"An arthro-dermato-pulmonary syndrome associated with anti-MDA5 antibodies","volume":"81","author":"Goussot","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0033","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/s10165-012-0637-6","article-title":"Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases","volume":"23","author":"Horai","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0034","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12890-015-0154-4","article-title":"Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?","volume":"15","author":"Ikeda","year":"2015","journal-title":"BMC Pulm Med."},{"issue":"2","key":"10.1016\/j.semarthrit.2020.03.007_bib0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10067-015-3001-3","article-title":"Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum","volume":"35","author":"Ma","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.03.007_bib0036","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.51.6813","article-title":"18F-FDG PET\/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis","volume":"51","author":"Morita","year":"2012","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0037","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3109\/14397595.2013.844390","article-title":"Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease","volume":"24","author":"Nara","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0038","doi-asserted-by":"crossref","DOI":"10.1186\/s12948-015-0031-y","article-title":"MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations","volume":"13","author":"Parronchi","year":"2015","journal-title":"Clin Mol Allergy"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0039","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","article-title":"HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody","volume":"105","author":"Tanizawa","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0041","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2169\/internalmedicine.9553-17","article-title":"Successful treatment of rapidly progressive unclassifiable idiopathic interstitial pneumonia with anti-melanoma differentiation-associated gene-5 antibody by intensive immunosuppressive therapy","volume":"57","author":"Koga","year":"2018","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.03.007_bib0042","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/bjd.15499","article-title":"Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules\/papules","volume":"177","author":"Koguchi-Yoshioka","year":"2017","journal-title":"Br JDermatol"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0043","first-page":"5","article-title":"Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis","volume":"19","author":"Suzuki","year":"2016","journal-title":"Respir Med Case Rep"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0044","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","article-title":"Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis","volume":"109","author":"Takada","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0045","first-page":"34","article-title":"Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report","volume":"11","author":"Yamada","year":"2018","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.03.007_bib0046","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2169\/internalmedicine.55.6055","article-title":"An autopsy case of anti-melanoma differentiation-associated gene-5 antibody-positive clinical amyopathic dermatomyositis complicated by rapidly progressive interstitial lung disease","volume":"55","author":"Yoshida","year":"2016","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0047","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000346573","article-title":"Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis","volume":"225","author":"Clottu","year":"2012","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.03.007_bib0048","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10067-015-2928-8","article-title":"Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review","volume":"35","author":"Gil","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.03.007_bib0049","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.annder.2013.04.083","article-title":"[Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case]","volume":"140","author":"Girard","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0050","doi-asserted-by":"crossref","unstructured":"Hayashi M, Aoki A, Asakawa K, Sakagami T, Kikuchi T, Takada T. Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate. 2017;5(4):e00235.","DOI":"10.1002\/rcr2.235"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0051","doi-asserted-by":"crossref","first-page":"33226","DOI":"10.1038\/srep33226","article-title":"Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.03.007_bib0052","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s11606-016-3769-0","article-title":"Anti-MDA5-positive dermatomyositis presenting as fever of unknown origin","volume":"31","author":"Lee","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.03.007_bib0053","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jdcr.2017.01.013","article-title":"Rapidly progressive melanoma differentiation\u2013associated protein 5\u2013positive amyopathic dermatomyositis in an HIV-positive patient","volume":"3","author":"Sharma","year":"2017","journal-title":"JAAD Case Reports"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.03.007_bib0054","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/key188","article-title":"Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis","volume":"57","author":"Kurasawa","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12890-018-0622-8","article-title":"MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report","volume":"18","author":"Alqatari","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.03.007_bib0056","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/14397595.2015.1014140","article-title":"A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment","volume":"27","author":"Koichi","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0057","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Kishida D, Shimojima Y. Effective administration of rituximab in anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease and refractory cutaneous involvement: a case report and literature review. 2017;2017:5386797.","DOI":"10.1155\/2017\/5386797"},{"issue":"21","key":"10.1016\/j.semarthrit.2020.03.007_bib0058","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2169\/internalmedicine.53.2769","article-title":"Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms","volume":"53","author":"Tamai","year":"2014","journal-title":"Intern Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.03.007_bib0059","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2169\/internalmedicine.56.7956","article-title":"Dermatomyositis with rapidly progressive interstitial lung disease treated with rituximab: a report of 3 cases in Japan","volume":"56","author":"Tokunaga","year":"2017","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.03.007_bib0060","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/annrheumdis-2014-205278","article-title":"Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody","volume":"73","author":"Zou","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0061","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000000984","article-title":"Successful treatment for refractory interstitial lung disease and pneumomediastinum with multidisciplinary therapy including tofacitinib in a patient with anti-MDA5 antibody-positive dermatomyositis","author":"Kato","year":"2019","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0062","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12890-017-0479-2","article-title":"Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias","volume":"17","author":"Okabayashi","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0063","unstructured":"Sasaki O, Dohi M Fau - Harada H, Harada H Fau - Imamura M, Imamura M Fau - Tsuchida Y, Tsuchida Y Fau - Yamaguchi K, Yamaguchi K Fau - Komai T, et al. A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis. (1687-9627 (Print))."},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0064","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcv068","article-title":"Anti-MDA5 dermatomyositis and progressive interstitial pneumonia","volume":"109","author":"Silveira","year":"2016","journal-title":"Qjm"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0065","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1378\/chest.13-0186","article-title":"Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140\/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis","volume":"144","author":"Teruya","year":"2013","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0066","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/resp.13054","article-title":"Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia","volume":"22","author":"Furusawa","year":"2017","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.03.007_bib0067","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/14397595.2013.852847","article-title":"Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases","volume":"24","author":"Ichiyasu","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0068","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1753465817708950","article-title":"Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies","volume":"11","author":"Ichiyasu","year":"2017","journal-title":"Ther Adv Respir Dis"},{"issue":"15","key":"10.1016\/j.semarthrit.2020.03.007_bib0069","doi-asserted-by":"crossref","first-page":"e0436","DOI":"10.1097\/MD.0000000000010436","article-title":"Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report","volume":"97","author":"Endo","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.03.007_bib0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.20452\/pamw.3055","article-title":"Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and antiMDA5 antibodies","volume":"125","author":"Gorka","year":"2015","journal-title":"Pol Arch Med Wewn"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0071","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.athoracsur.2008.03.053","article-title":"Prolonged extracorporeal membrane oxygenation and circulatory support as bridge to lung transplant","volume":"86","author":"Broome","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0072","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3899\/jrheum.171047","article-title":"Successful lung transplantation in a case of rapidly progressive interstitial lung disease associated with antimelanoma differentiation-associated gene 5 antibodies","volume":"45","author":"Leclair","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0073","article-title":"Rapidly progressive interstitial lung disease due to anti-melanoma differentiation associated protein-5 requiring a bilateral lung transplant, and complicated by kennel cough","volume":"28","author":"Deitchman","year":"2019","journal-title":"Respir Med Case Rep"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.03.007_bib0074","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","article-title":"Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review","volume":"39","author":"Huang","year":"2019","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.03.007_bib0075","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.03.007_bib0076","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/art.39021","article-title":"Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study","volume":"67","author":"Bernstein","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0077","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/RHU.0b013e3182676089","article-title":"Survival and extrapulmonary course of connective tissue disease after lung transplantation","volume":"18","author":"Takagishi","year":"2012","journal-title":"J Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0078","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2016.12.013","article-title":"Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease","volume":"36","author":"Courtwright","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2013an update from the pulmonary transplantation council of the international society for heart and lung transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.03.007_bib0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1191\/0961203305lu2158oa","article-title":"Polymyositis\/dermatomyositis-associated lung disease: analysis of a series of 81 patients","volume":"14","author":"Selva-O'Callaghan","year":"2005","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.03.007_bib0081","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11748-012-0106-3","article-title":"Living-donor lobar lung transplantation for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of a case","volume":"61","author":"Shoji","year":"2013","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.03.007_bib0082","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","article-title":"A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature","volume":"91","author":"Chaisson","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.03.007_bib0083","first-page":"444","article-title":"A severe anti MDA-5 antibodies associated amyopathic dermatomyositis","volume":"95","author":"El Euch","year":"2017","journal-title":"Tunis Med"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0084","article-title":"Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant","author":"Chan","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.03.007_bib0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMc1900045","article-title":"Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med."}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220300809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220300809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:04:42Z","timestamp":1758733482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220300809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0049017220300809"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.007","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}